Ann: Creso signs distribution agreement in Switzerland - CannaQIX, page-95

First 95 Last

Share
Profile

Follow
Pilbars

1,167 Posts.

448

06/12/17

12:40

Post #: 29416616
Share

Originally posted by FraserJC ↑

The ambition is not the problem. The cost implications are.

In general, young companies flourish when they are really good at a small number of things. Then, as their reputation grows, they can branch into new products or markets. This approach minimises early cash-burn and significantly increases the chances of long-term success.

The reason is quite simple. A company's cost function depends on several variables, most importantly the:

1. number of products (SKUs) they produce or sell; and
2. number of geographic markets they serve.

It therefore follows that, the fewer products and the fewer geographic markets that a company enters, the lower its initial costs. Basically, concentrating on only one market or product line etc results in significant economies of scale, whereas a diversified start-up never reaches sufficient scale in any product or market to achieve said economies.

This is partly why 50% of all new firms die within 5 years (at least in NZ).

So, while I applaud CPH's ambition and vision, the financial realities paint a far less appealing picture to me.

DYOR etc.

Expand

In case any newbies are wondering , here's where we stand :

In one corner we have FrazerJC - Operating out of his mum's suburban bedsit in Regional New Zealand on his IPhone. Managed to break even on the NZ stock exchange the last couple of years.

In the other corner we have : http://cresopharma.com/profile/board-of-directors/

Who do you think has a better grasp of the Pharmaceutical industry and the direction the company should be headed ?

Here's a hint if you're still unsure - One of the two started an international company from scratch that multibagged and the other did SFA.

Last edited by Pilbars: 06/12/17

CPH Price at posting: 94.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon